Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

BioLineRx (BLRX) Operating Income: 2012-2024

Historic Operating Income for BioLineRx (BLRX) over the last 13 years, with Dec 2024 value amounting to -$20.4 million.

  • BioLineRx's Operating Income rose 60.11% to -$2.3 million in Q2 2025 from the same period last year, while for Jun 2025 it was -$14.5 million, marking a year-over-year increase of 65.06%. This contributed to the annual value of -$20.4 million for FY2024, which is 58.93% up from last year.
  • According to the latest figures from FY2024, BioLineRx's Operating Income is -$20.4 million, which was up 58.93% from -$49.7 million recorded in FY2023.
  • In the past 5 years, BioLineRx's Operating Income registered a high of -$20.4 million during FY2024, and its lowest value of -$49.7 million during FY2023.
  • In the last 3 years, BioLineRx's Operating Income had a median value of -$29.2 million in 2022 and averaged -$33.1 million.
  • Its Operating Income has fluctuated over the past 5 years, first slumped by 70.44% in 2023, then soared by 58.93% in 2024.
  • BioLineRx's Operating Income (Yearly) stood at -$22.9 million in 2020, then declined by 8.07% to -$24.8 million in 2021, then decreased by 17.68% to -$29.2 million in 2022, then crashed by 70.44% to -$49.7 million in 2023, then soared by 58.93% to -$20.4 million in 2024.